Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-11-13

Clinical Trial Update: Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of immunization with Plasmodium falciparum sporozoites under chloroquine or chloroquine/azithromycin prophylaxis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Chloroquine (chloroquine)
  • PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Malaria, Falciparum | Phase 1, Phase 2 | Status: WITHDRAWN